End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.13 CNY | -0.95% | -0.95% | -6.57% |
25/04 | Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
11/04 | Harbin Pharma to Upgrade Subsidiary's Production Base for 50 Million Yuan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-6.57% | 109.11Cr | |
+29.98% | 68TCr | |
+32.02% | 59TCr | |
-3.52% | 36TCr | |
+18.59% | 33TCr | |
+4.07% | 28TCr | |
+16.68% | 24TCr | |
+9.54% | 21TCr | |
-8.59% | 20TCr | |
+7.09% | 17TCr |
- Stock Market
- Equities
- 600664 Stock
- News Harbin Pharmaceutical Group Co., Ltd.
- Roxatidine Hydrochloride for Injection of Harbin Pharma's Subsidiary Passes Drug Regulator's Evaluation